Biotec BetaGlucans is pleased to confirm that the first technical batch of its new Woulgan^® Biogel product for advanced wound healing has been successfully completed at Austrian company Sanochemia Pharmaceuticals AG.

Sanochemia has also been elected to perform the three validation batches that will follow over the coming months. 

During the coming year Biotec BetaGlucans will decide on the long term subcontractor to be used for the commercial production to follow after the expected launch of product.